FDA's B Dunn

Discussion in 'BiogenIdec' started by anonymous, Nov 9, 2020 at 4:23 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Any you are the expert and know that definitively? Oh tell us swami what do you see in your crystal ball? Public Citizen is demanding an investigation.
     

  2. anonymous

    anonymous Guest

    Did FDA just hire a new director of neurology to replace Billy Dunn?

    The Office of New Drugs is undergoing a reorganization. This site will be updated in the near future. Please check back often. For more information, please visit: Reorganization of the Office of New Drugs with Corresponding Changes to the Office of Translational Sciences and the Office of Pharmaceutical Quality. Until this page is updated, please contact druginfo@fda.hhs.gov or newdrugstransitionteam@fda.hhs.gov for updates and additional information.

    Director: Mary T. Thanh Hai, M.D.
     
  3. anonymous

    anonymous Guest

    If Billy Dunn is gone from the FDA, this is really big news
     
  4. anonymous

    anonymous Guest

    Is he still with the FDA or at Biogen?
     
  5. anonymous

    anonymous Guest

  6. anonymous

    anonymous Guest

    He appears to be gone. His number has been reassigned at the FDA.
     
  7. anonymous

    anonymous Guest

    Heard he’s the new Alzheimer’s TBM in Boston.
     
  8. anonymous

    anonymous Guest

    Has Dunn really left the FDA to go into industry? That would not be good for aducanumab since he worked so much with Biogen and wanted it approved
     
  9. anonymous

    anonymous Guest

    He is still very much there and gunning Adu. He is Biogen's super hero
     
  10. anonymous

    anonymous Guest

    Too bad there at least two more signers above him.